desipramine has been researched along with Shock in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hughes, PL | 1 |
Rome, JD | 1 |
1 other study available for desipramine and Shock
Article | Year |
---|---|
Cardiopulmonary collapse associated with an overdose of desipramine.
Topics: Adult; Desipramine; Emergencies; Female; Humans; Shock; Suicide, Attempted | 1984 |